Liao Yi-Xuan, Chen Ya-Hong
Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Chin Med J (Engl). 2020 Sep 5;133(17):2098-2103. doi: 10.1097/CM9.0000000000000920.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has been changing for nearly 20 years. GOLD has moved from single assessment using spirometry to a more comprehensive assessment of chronic obstructive pulmonary disease using spirometry, symptoms and exacerbation history. And subsequently, a new assessment system for chronic obstructive pulmonary disease separated spirometric grades from the old assessment system, and classified patients only according to their symptoms and history of exacerbation. The distribution, clinical characteristics, treatment, and prognosis of the new subgroups were different from the old ones. In this review, we will present a brief profile of changes made to the disease assessment method of GOLD, based on the relevant existing literature.
慢性阻塞性肺疾病全球倡议(GOLD)已经历了近20年的变革。GOLD已从单纯使用肺量计进行评估,转变为使用肺量计、症状和急性加重病史对慢性阻塞性肺疾病进行更全面的评估。随后,一种新的慢性阻塞性肺疾病评估系统将肺量计分级与旧评估系统分开,仅根据患者的症状和急性加重病史进行分类。新亚组的分布、临床特征、治疗和预后与旧亚组不同。在本综述中,我们将根据现有相关文献,简要介绍GOLD疾病评估方法的变化情况。